Like many other chronic health conditions, vitiligo is often misunderstood—and due to the visible symptoms it causes, it’s undeniably stigmatized. Vitiligo is a chronic autoimmune condition that ...

The panel navigates unmet needs surrounding the vitiligo treatment landscape. Jeffrey D. Dunn, PharmD, MBA: How would you define the unmet need, given what we have and this disease state? David ...

A variety of treatment options for vitiligo are explored by Drs Dunn, Rosmarin, and King. Jeffrey D. Dunn, PharmD, MBA: We’ve talked about topical steroids, topical calcineurin inhibitors, and light ...

Vitiligo is an autoimmune condition that targets the melanocytes, which are the skin cells that produce melanin and give your skin its color. Areas of your skin affected by vitiligo show up as white ...

Please provide your email address to receive an email when new articles are posted on . Repigmentation of at least 80% was achieved in 36% of areas treated with ASCS compared with 0% of control areas ...

Since the Bronze Age, humans have recorded cases of vitiligo -- and attempted to cure it. "3,400 years ago, ancient Indian texts called the Vedas actually wrote about vitiligo specifically and ...

CARLSBAD, Calif. — When patients with vitiligo see Jessica Shiu, MD, PhD, for the first time, some mention that prior healthcare providers have told them that vitiligo is merely a cosmetic issue — ...

Please provide your email address to receive an email when new articles are posted on . Almirall S.A. and Inserm Transfert have entered an agreement to advance research in vitiligo treatment, the two ...

A new study, led by researchers from the University of California, Irvine, reveals the unique cell-to-cell communication networks that can perpetuate inflammation and prevent repigmentation in ...

Vitiligo is an autoimmune condition that causes areas of skin to lose color or pigment. It isn’t just visible to others. You can see it on yourself. And I talk with people all the time about how this ...

More than 80,000 adults and teenagers across England suffering with a chronic skin condition could have their lives transformed after NICE today (Tuesday, 24 February) recommended the first licensed ...

On 12 March 2026, China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company ...